Bosh, 32, didn't play after the All-Star break but was hoping to return during the playoffs. The Heat resisted his intentions to play due to the dangers of competing while taking blood thinners.
Bosh's representatives reportedly pitched a proposal in which Bosh would take the blood-thinning medication early in the day so the medication would be out of his system by game time. They said blood tests revealed the medicine would be out of his system 8 to 12 hours after being taken.
Miami and its team doctors were opposed to the idea due to the possibility of Bosh suffering a hard fall or something occurring that would cause him to bleed internally during a contest.
The Heat said they wouldn't allow Bosh to return until he was 100 percent.
Bosh and the Heat finally agreed on May 4 that he wouldn't play in the postseason.
This was the second straight season that Bosh didn't finish due to blood clot issues.
Bosh averaged 19.1 points and 7.4 rebounds before the health setback.
He is under contract to the Heat through the 2018-19 season. Team president Pat Riley recently said there will be conditions that dictate whether Bosh returns next season.
"We are very encouraged by trying to find a way over the next two or three months to find a protocol and program to get him back playing," Riley told reporters. "That's always been our objective. It's the X-factor in everything we're trying to do this summer."